Literature DB >> 3489227

Endosteal new bone formation in the long bones of adjuvant treated rats.

K Tomoda, M Kitaoka, K Iyama, G Usuku.   

Abstract

Histopathological changes were examined mainly in the diaphyseal parts of long bones, especially femur in adjuvant-treated male Lewis-SPF rats, with reference to clinical symptoms of chronic osteoarthritis. The diaphyseal bone marrow of long bones in these rats sequentially showed three different processes of chronic pathological changes, which, however, partly overlapped each other. Initially, multiple epitheloid cell granulomas or granulomatous lesions containing fibrin deposits began to appear in the marrow space about 22 days after adjuvant injection, when the joint score of arthritis reached a peak in severity. Secondly, about a week after appearance of the granulomas, there occurred the intramembranous endosteal new bone formation proceeding from the endosteum towards the granulomatous lesions. The bone formation reached a maximum about 64 days after the treatment, when the redness of joints of feet and hands was already sedated. Finally, about 40 days after occurrence of the second event, the newly growing bone matrix began to be actively resorbed simultaneously. On the other hand, in the bone marrow of metaphyseal parts of long bones in these rats, severe acute osteomyelitis was observed from an early stage, with marked destruction of bone trabeculae and simultaneous new bone formation. In the diaphyseal bone marrow of affected long bones, the epitheloid cell granulomas appear to induce the endosteal new bone formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489227     DOI: 10.1016/s0344-0338(86)80112-1

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats.

Authors:  E Tigka; I Daskala; G Rallis; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.

Authors:  M A Hayward; G A Howard; R G Neuman; D D Wood; B M Weichman; D C Van Sickle
Journal:  Agents Actions       Date:  1989-03

3.  Effects of time of initial exposure to MSV sarcoma on bone induction by dentine matrix implants and on orthotopic femora.

Authors:  Krzysztof Włodarski; Paweł Włodarski; Ryszard Galus; Aniela Brodzikowska
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.